Pyruvate kinase activators may benefit vaso-occlusive crisis in sickle cell disease
A pair of pyruvate kinase (PKA) activators have been linked to increased oxygen affinity and reduced propensity for red blood cell sickling in patients with sickle cell disease in vitro, according to new findings. In data presented at the 2022 Annual Meeting of the American Society of Hematology (ASH) in New Orleans this week, a …
Pyruvate kinase activators may benefit vaso-occlusive crisis in sickle cell disease Read More »